Vaxart, Inc. (VXRT)
0.6897
+0.01
(+1.80%)
USD |
OTCM |
May 13, 16:00
Vaxart Cash from Investing (Quarterly) : -0.676M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Inovio Pharmaceuticals, Inc. | -0.0582M |
| Capricor Therapeutics, Inc. | -- |
| Allogene Therapeutics, Inc. | 33.61M |
| Agenus, Inc. | 68.95M |
| Curis, Inc. | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.054M |
| Cash from Financing (Quarterly) | -0.338M |
| Free Cash Flow | 14.80M |
| Free Cash Flow Per Share (Quarterly) | -0.0103 |
| Free Cash Flow to Equity (Quarterly) | -1.659M |
| Free Cash Flow to Firm (Quarterly) | -2.000M |
| Free Cash Flow Yield | 9.13% |